Open Label Study of Everolimus (RAD001) in Patients With Segmental Overgrowth Syndrome
Clinical trial NCT02569125 · WITHDRAWN
Trial details
- NCT number
- NCT02569125
- Sponsor
- Jochen Roessler
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.